25.10.2014 Views

Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

Rapporto annuale 2007 - Istituto di Ricerche Farmacologiche Mario ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IRFMN<br />

CURRICULUM<br />

Livio Garattini : laureato in Scienze Economiche nel Marzo 1983 presso l’Università Bocconi <strong>di</strong> Milano.<br />

Attività formative: “King’s Fund College”, Londra: frequentazione <strong>di</strong> corsi <strong>di</strong> management sanitario;<br />

“Centre for Health Economics”, York: analisi bibliografica <strong>di</strong> pubblicazioni sul NHS inglese; “Ecole<br />

Nationale de la Santé Publique”, Rennes: frequentazione <strong>di</strong> corsi <strong>di</strong> management sanitario.<br />

Aree <strong>di</strong> interesse: Economia e Politica sanitaria.<br />

Attualmente: Direttore CESAV (Centro <strong>di</strong> Economia Sanitaria A. e A. Valenti dell’<strong>Istituto</strong> M. Negri);<br />

1981-1983: ricercatore c/o l’<strong>Istituto</strong> M. Negri;<br />

1983-1984: impiegato c/o la Banca Commerciale Italiana <strong>di</strong> Milano;<br />

Settembre 1984-Luglio 1985: consulente senior c/o la “Sogess srl” <strong>di</strong> Milano;<br />

1985-1990: ricercatore c/o l’Università Bocconi <strong>di</strong> Milano.<br />

Principali pubblicazioni:<br />

• Garattini L, De Compadri P, Clemente R, Cornago D (2003) “Economic Evaluations in Italy: a Review of the Literature”<br />

International Journal of Technology Assessment in Health Care 19(4): 685-697.<br />

• Garattini L, Ghislan<strong>di</strong> S (2006) “Off-patent drugs in Italy- A short-sighted view?” The European Journal of Health<br />

Economics 7(1): 79-83.<br />

• Garattini L, Ghislan<strong>di</strong> S (<strong>2007</strong>) “Should we really worry about “launch delays” of new drugs in OECD countries?”<br />

(E<strong>di</strong>toriale) The European Journal of Health Economics 8(1): 1-3.<br />

• Cornago D, Li Bassi L, De Compadri P, Garattini L (<strong>2007</strong>) “Pharmacoeconomic stu<strong>di</strong>es in Italy: a critical review of the<br />

literature” The European Journal of Health Economics 8(2):89-95.<br />

• Garattini L, Cornago D De Compadri P (<strong>2007</strong>) “Pricing and reimbursement of in-patent drugs in seven European<br />

countries: A comparative analysis” Health Policy 82:330-339.<br />

• Koleva D, Motterlini N, Banfi P, Garattini L (<strong>2007</strong>) “Healthcare costs of COPD in Italian referral centres: A prospective<br />

study” Respiratory Me<strong>di</strong>cine 101:2312-2320.<br />

332<br />

RAPPORTO ATTIVITA’ <strong>2007</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!